Osama Hamdy, MD, PhD
Medical Advisor
Osama Hamdy, MD, PhD is a senior endocrinologist and Medical Director of the Joslin Obesity Clinical Program, and Director of the Inpatient Diabetes Program at Joslin Diabetes Center. He is also an Associate Professor of Medicine at Harvard Medical School. He is a world recognized expert and thought leader with 34 years of extensive clinical experience in nutrition and obesity research.
His lab led to innovations in how we manage obesity in patients with type 1 or type 2 diabetes. Dr. Hamdy’s research discovered that 7% weight loss in obese patients with and without diabetes significantly improves vascular endothelial function, insulin sensitivity and markers of inflammation. Dr. Hamdy was a co-investigator in landmark studies: the “Diabetes Prevention Program” and “the Look AHEAD Study.” Dr. Hamdy founded the “Weight Achievement and Intensive Treatment” (Why WAIT) program, helping patients with diabetes to be less dependent on diabetes medications. Dr. Hamdy co-chaired the task force that developed the global transcultural Diabetes Nutrition Algorithm (tDNA). His research led to changes in the standards of diabetes care and lifestyle management by the American Diabetes Association and the American Association of Clinical Endocrinologists.
Dr. Hamdy received the Michaela Modan Award of the American Diabetes Association and the Compassionate Caregiver Award of the Kenneth Schwartz Center. He has more than 150 peer-reviewed original articles, reviews and book chapters. He is also the author of the Harvard Health Publication “The Diabetes Breakthrough” reversing diabetes through weight management. He is on the editorial review board of many medical journals including Lancet, JAMA, British Medical Journal, Diabetes Care and Current Diabetes Report.